| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 94 | 11.0x | 17.4x | Top tier | |
Growth | 68 | 15.1% | 7.1% | Top tier | |
Quality | 80 | 13.6% | 4.5% | Top tier | |
Safety | 60 | 1.5x | 2.6x | Around median | |
Capital Return | 57 | 10.70% | 0.18% | Around median | |
Momentum | 14 | -33.3% | 1.3% | Bottom tier | |
Sentiment | 64 | 3 | 3 | Around median |
The floor: what the company is worth if growth stopped today
10-year US Treasury yield 5.31% as of 2026-10-05. Estimates computed from company data and analyst targets, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
CareCloud, Inc. is a provider of healthcare information technology solutions, operating to deliver digital platforms and services to support the clinical, financial, and administrative aspects of healthcare providers. The company's broad portfolio includes electronic health records (EHR), practice management, and revenue cycle management (RCM) solutions, along with patient engagement platforms. Through recent acquisitions, such as its acquisition of Medsphere, the company expanded its scope to include hospitals and internal healthcare systems, adding products like Wellsoft for emergency departments and CareView for inpatient medical records, transitioning the company from a focus on outpatient clinics to covering the entire healthcare continuum.
CareCloud increasingly relies on artificial intelligence as a core part of its strategy to increase efficiency and develop its products. The company is adopting a three-dimensional AI path: improving the efficiency of internal operations and reducing costs, integrating AI technologies into existing platforms to increase their value to customers, and developing new and independent AI products such as stratusAI Front Desk Agent and cirrusAI Notes. This approach aims to diversify revenue streams and enhance profit margins while maintaining the current customer base.
In the first quarter of fiscal year 2026, the company reported revenues of $31.3 million, an increase of 13% compared to $27.6 million in the same quarter of the previous year. GAAP operating income was $1 million, while net income was $922,000, an expected decrease primarily due to increased amortization of intangible assets and integration costs associated with the Medsphere acquisition. The company also generated free cash flows of $2.4 million and reaffirmed its full-year guidance, expecting revenues between $128 million and $132 million.
Automated analysis for informational purposes only — not investment advice.
CareCloud stock currently trades at a valuation reflecting positive expectations, with the analyst consensus recommending a buy. The current price trades below the analyst average price target of $3.13, with a range between $3.00 and $3.25. This valuation reflects analysts' confidence in the company's growth and AI integration strategy, despite temporary integration costs.
Figures in the text are as of 2026-08-04; the live price is shown at the top of the page.
CareCloud is integrating AI into its existing platforms such as electronic health records (EHR) and practice management. This makes the software smarter and more predictive, such as optimizing scheduling and patient intake in the practice management system. The goal is to enhance the value of these products for current customers without requiring them to purchase new solutions, thereby increasing customer retention rates.
The redemption of the Series B preferred stock, scheduled for May 15, removes the burden of high-cost dividends associated with these shares. This redemption was funded through a new $50 million credit facility at a lower cost. This simplification of the capital structure reduces the company's average cost of capital and frees up cash flows that can be directed toward growth investments and acquisitions.
The Medsphere acquisition in 2025 shifted CareCloud from a focus on outpatient clinics to covering hospitals and healthcare systems. The acquisition added products like Wellsoft for emergency departments and CareView for hospitals. This provides the company with significant opportunities to cross-sell its existing services, such as revenue cycle management (RCM) and AI solutions, to a larger and more complex customer base.
In the first quarter of 2026, the company reported revenues of $31.3 million, a 13% increase from the same quarter of the previous year. GAAP net income was approximately $922,000, which is lower than the previous year due to Medsphere integration costs. However, the company maintained positive free cash flows of $2.4 million and reaffirmed its full-year guidance.
